← Trials/Trial dossier/NCT06611202
Enhancing Mobility and Mental Health in Dementia Patients
Enhancing Mobility and Mental Health in Dementia Patients: A Multidisciplinary Six-Minute Walking Group Pilot Study
Lead sponsor
Asset
Clonazepam
Listed sites
1
Recruiting sites
-
Enrollment
6
estimated
Study population
Mixed / unspecified dementia
Key I/E criterion
•Age ≥65
Primary endpoint
•Mobility
Footprint
Where this trial recruits
Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.
Identifiers
Registered as
Timeline
Milestones
Assets
Drug assets
Study populations
Who this study enrolls
Eligibility
Who can enroll
Inclusion criteria
Exclusion criteria
Endpoints (5)
What's being measured
Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.
Coverage by outcome category
Global cognition
1 endpointmental health and cognition
Time frame:8 weeks
categorical status, descriptive
Function / daily living
1 endpointFunctional tasks
Time frame:8 weeks
descriptive
Behavior / neuropsychiatric
1 endpointmental health and cognition
Time frame:8 weeks
Neuropsychiatric Inventory (NPI)
event count, event
Other clinical outcomes
2 endpointsMobility
Time frame:8 weeks
descriptive
Mobility
Time frame:8 weeks
descriptive
Provenance
Sources
Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 21, 2026 snapshot.